Were the BWXT CEO’s BWX Technologies share sales pre-planned under Rule 10b5-1?

Yes. A footnote states the sales were effected under a Rule 10b5-1 trading plan adopted by Rex Geveden on 2025-08-11. Such plans allow insiders to schedule trades in advance, helping separate trading decisions from day-to-day information.

BWX Technologies, Inc. Insider Trading Activity

Q: How many BWX Technologies (BWXT) shares did CEO Rex Geveden sell?

Rex Geveden sold 10,000 shares of BWX Technologies common stock. The Form 4 shows four open-market sale transactions on 2026-05-12, with individual trade sizes of 1,318, 1,402, 3,570, and 3,710 shares, totaling 10,000 shares sold.

Q: How many BWX Technologies (BWXT) shares does Rex Geveden hold after these sales?

After the reported sales, Rex Geveden directly holds 202,491 BWX Technologies common shares. This figure reflects his remaining direct ownership position following the 10,000 shares sold in the open-market transactions disclosed for 2026-05-12.

Q: What type of transactions did BWXT report for its CEO’s BWX Technologies shares?

The filing reports four open-market sales of BWX Technologies common stock. Each transaction is coded “S” for sale and classified as a non-derivative transaction, meaning they involved direct common shares rather than options or other derivative securities.

Q: Did the BWXT CEO exercise any options or derivatives in this Form 4 filing?

No. The Form 4 lists only non-derivative common stock sales with transaction code “S.” The derivative section is empty, and the derivative summary shows no option exercises or other derivative transactions reported alongside these common stock sales.

BWX Technologies, Inc. President and CEO Rex D. Geveden sold 10,000 shares of common stock in open-market transactions.

Accepted by SEC EDGAR 05/12/2026 - 04:55 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

BWX Technologies, Inc. President and CEO Rex D. Geveden sold 10,000 shares of common stock in open-market transactions. The sales occurred on 2026-05-12 at weighted average prices around $203–$207 per share, executed in four separate trades.

The filing states these transactions were made under a pre-arranged Rule 10b5-1 trading plan adopted on 2025-08-11, indicating they were scheduled in advance. Following the transactions, Geveden directly owns 202,491 shares of BWX Technologies common stock.

Insider Trade Summary 10b5-1

Net Seller: 10,000 shares

Net Sell 4 txns

Insider Geveden Rex D

Role President and CEO

Sold 10,000 shs ($2.05M)

Share of Position Sold 4.7%

Type	Security	Shares	Price	Value
Sale	Common Stock	3,710	$203.7809	$756K
Sale	Common Stock	3,570	$204.6477	$731K
Sale	Common Stock	1,402	$205.7828	$289K
Sale	Common Stock	1,318	$207.13	$273K

Holdings After Transaction: Common Stock — 202,491 shares (Direct)

Holdings Before and After: Common Stock, 212,491 to 202,491 shares (Direct)

Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (4)

F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/11/2025.
F2. The price in Column 4 is a weighted average price. The shares were sold at prices ranging from $203.2900 to $204.2700 inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F3. The price in Column 4 is a weighted average price. The shares were sold at prices ranging from $204.3050 to $205.1600 inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F4. The price in Column 4 is a weighted average price. The shares were sold at prices ranging from $205.3500 to $206.2500 inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many BWX Technologies (BWXT) shares did CEO Rex Geveden sell?

Rex Geveden sold 10,000 shares of BWX Technologies common stock. The Form 4 shows four open-market sale transactions on 2026-05-12, with individual trade sizes of 1,318, 1,402, 3,570, and 3,710 shares, totaling 10,000 shares sold.

At what prices did the BWXT CEO sell his BWX Technologies shares?

The reported weighted average sale prices were about $203.78 to $207.13 per share. Footnotes explain that actual trades occurred in ranges between $203.29 and $206.25, and detailed price breakdowns are available upon request from the company or SEC staff.

How many BWX Technologies (BWXT) shares does Rex Geveden hold after these sales?

After the reported sales, Rex Geveden directly holds 202,491 BWX Technologies common shares. This figure reflects his remaining direct ownership position following the 10,000 shares sold in the open-market transactions disclosed for 2026-05-12.

What type of transactions did BWXT report for its CEO’s BWX Technologies shares?

The filing reports four open-market sales of BWX Technologies common stock. Each transaction is coded “S” for sale and classified as a non-derivative transaction, meaning they involved direct common shares rather than options or other derivative securities.

Did the BWXT CEO exercise any options or derivatives in this Form 4 filing?

No. The Form 4 lists only non-derivative common stock sales with transaction code “S.” The derivative section is empty, and the derivative summary shows no option exercises or other derivative transactions reported alongside these common stock sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Geveden Rex D

(Last)

(First)

(Middle)

800 MAIN STREET

4TH FLOOR

(Street)

LYNCHBURG

VIRGINIA

24504

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BWX Technologies, Inc. [ BWXT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/12/2026		S⁽¹⁾		3,710	D	$203.7809⁽²⁾	208,781	D
Common Stock	05/12/2026		S⁽¹⁾		3,570	D	$204.6477⁽³⁾	205,211	D
Common Stock	05/12/2026		S⁽¹⁾		1,402	D	$205.7828⁽⁴⁾	203,809	D
Common Stock	05/12/2026		S⁽¹⁾		1,318	D	$207.13	202,491	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/11/2025.

2. The price in Column 4 is a weighted average price. The shares were sold at prices ranging from $203.2900 to $204.2700 inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

3. The price in Column 4 is a weighted average price. The shares were sold at prices ranging from $204.3050 to $205.1600 inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

4. The price in Column 4 is a weighted average price. The shares were sold at prices ranging from $205.3500 to $206.2500 inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Rex D. Geveden, by Alexander D. Cobey, attorney-in-fact	05/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR